NORD Responds to JAMA Article Claiming Drugs for Rare Diseases Such as Mesothelioma Could Have Safety Issues
The National Organization for Rare Disorders (NORD) responded to the editors of the Journal of the American Medical Association (JAMA) regarding an article they recently published claiming that orphan disease clinical trials may not be managed as rigorously as those for other illnesses. There are close to 7,000 rare diseases in the United States, and many [...]